Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.

Hettmer S, Liu J, Miller CM, Lindsay MC, Sparks CA, Guertin DA, Bronson RT, Langenau DM, Wagers AJ.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20002-7. doi: 10.1073/pnas.1111733108. Epub 2011 Nov 30.

2.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

3.

Gene expression profiling in sarcomas.

Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD.

Crit Rev Oncol Hematol. 2007 Aug;63(2):111-24. Epub 2007 Jun 6. Review.

PMID:
17555981
4.

The Evolution of Pediatric Soft Tissue Sarcoma Classification in the Last 50 Years.

Alaggio R, Coffin CM.

Pediatr Dev Pathol. 2015 Nov-Dec;18(6):481-94. doi: 10.2350/15-07-1666-MISC.1. Epub 2015 Dec 23. Review.

PMID:
26701753
5.

The Hippo signal transduction pathway in soft tissue sarcomas.

Mohamed AD, Tremblay AM, Murray GI, Wackerhage H.

Biochim Biophys Acta. 2015 Aug;1856(1):121-9. doi: 10.1016/j.bbcan.2015.05.006. Epub 2015 Jun 4. Review.

PMID:
26050962
6.

MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.

Fujiwara T, Kunisada T, Takeda K, Uotani K, Yoshida A, Ochiya T, Ozaki T.

Biomed Res Int. 2014;2014:592868. doi: 10.1155/2014/592868. Epub 2014 Aug 4. Review.

7.

Mesenchymal to epithelial transition in sarcomas.

Yang J, Du X, Wang G, Sun Y, Chen K, Zhu X, Lazar AJ, Hunt KK, Pollock RE, Zhang W.

Eur J Cancer. 2014 Feb;50(3):593-601. doi: 10.1016/j.ejca.2013.11.006. Epub 2013 Nov 28. Review.

PMID:
24291235
8.

Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.

Beck AH, West RB, van de Rijn M.

Virchows Arch. 2010 Feb;456(2):141-51. doi: 10.1007/s00428-009-0774-2. Epub 2009 May 2. Review.

9.

The role of inflammation in sarcoma.

Radons J.

Adv Exp Med Biol. 2014;816:259-313. doi: 10.1007/978-3-0348-0837-8_11. Review.

PMID:
24818727
10.

Updates in the approach to intrathoracic sarcomas.

Thway K, Jordan S, Fisher C, Nicholson AG.

Histopathology. 2015 Dec;67(6):755-70. doi: 10.1111/his.12771. Epub 2015 Sep 3. Review.

PMID:
26132510
11.

MicroRNAs in the pathobiology of sarcomas.

Sarver AE, Subramanian S.

Lab Invest. 2015 Sep;95(9):987-94. doi: 10.1038/labinvest.2015.81. Epub 2015 Jun 29. Review.

12.

Rhabdomyosarcomas: an overview on the experimental animal models.

Zanola A, Rossi S, Faggi F, Monti E, Fanzani A.

J Cell Mol Med. 2012 Jul;16(7):1377-91. doi: 10.1111/j.1582-4934.2011.01518.x. Review.

13.

Epigenetic and genetic changes in soft tissue sarcomas: a review.

Soini Y.

APMIS. 2016 Nov;124(11):925-934. doi: 10.1111/apm.12600. Epub 2016 Sep 27. Review.

PMID:
27670825
14.

The roles of microRNAs in sarcomas.

Drury R, Verghese ET, Hughes TA.

J Pathol. 2012 Aug;227(4):385-91. doi: 10.1002/path.4037. Epub 2012 May 23. Review.

PMID:
22488672
15.

The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.

Rello-Varona S, Herrero-Martín D, Lagares-Tena L, López-Alemany R, Mulet-Margalef N, Huertas-Martínez J, Garcia-Monclús S, García Del Muro X, Muñoz-Pinedo C, Tirado OM.

Front Oncol. 2015 Apr 7;5:82. doi: 10.3389/fonc.2015.00082. eCollection 2015. Review.

Supplemental Content

Support Center